Recent Advances in Antiemetics: New Formulations of 5ht3-Receptor Antagonists

Cancer Management and Research- New Zealand

doi 10.2147/cmar.s166912

Full Text

Abstract

Available in

Categories

Date

July 1, 2018

Authors

Niesha Griffith

Lee Schwartzberg

Publisher

Informa UK Limited

Related search

Recent Advances on Toll-Like Receptor 4 Modulation: New Therapeutic Perspectives

Future Medicinal Chemistry

Molecular Medicine

English

Patient Perceptions of the Side-Effects of Chemotherapy: The Influence of 5HT3 Antagonists

British Journal of Cancer

Cancer Research

English

Expression, Purification and Stabilization of the Mouse 5HT3 Receptor

Biophysical Journal

English

Recent Advances in Gene Manipulation and Nicotinic Acetylcholine Receptor Biology

Biochemical Pharmacology

English

Synthesis of New Cardioselective M2 Muscarinic Receptor Antagonists.

Chemical and Pharmaceutical Bulletin

English

Fish Locomotion: Recent Advances and New Directions

Annual Review of Marine Science

English

Selective MT2 Melatonin Receptor Antagonists Block Melatonin-Mediated Phase Advances of Circadian Rhythms

Molecular Biology

English

Mineralocorticoid Receptor Antagonists: New Extended Roles in Cardio- And Nephroprotection

Medical Council

English

Recent Advances in Pancreatology

Frontiers in Physiology

English